ロード中...
Current and future pharmacological therapies for NAFLD/NASH
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide, and there is no approved pharmacotherapy. The efficacy of vitamin E and pioglitazone has been established in nonalcoholic steatohepatitis (NASH), a progressive form of NAFLD. GLP-1RA and SGLT2 inhibitors, which a...
保存先:
| 出版年: | J Gastroenterol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Japan
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5847174/ https://ncbi.nlm.nih.gov/pubmed/29247356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-017-1415-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|